MedPath

BAXTER HEALTHCARE CORPORATION

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Ease of Use and Blood Clotting for the Gambro Polyflux HD-C4 Big Dialyzer

Completed
Conditions
Chronic Kidney Failure
First Posted Date
2008-04-16
Last Posted Date
2025-03-13
Lead Sponsor
Vantive Health LLC
Target Recruit Count
33
Registration Number
NCT00659724
Locations
🇺🇸

Advanced Dialysis Center of Easton, Easton, Maryland, United States

🇺🇸

Advanced Dialysis Center of Potomac, Arlington, Virginia, United States

Comparative Effects Of Dialysate Flow Rate And Membrane Packing On The Performance Of Dialyzers Used For Hemodialysis

Not Applicable
Completed
Conditions
Chronic Renal Disease
Chronic Kidney Disease
Interventions
Device: Optiflux 160NR
Device: HD-C4 Small
Device: Polyflux HD-C4 Big
Device: Optiflux 200NR
First Posted Date
2008-03-14
Last Posted Date
2025-03-24
Lead Sponsor
Vantive Health LLC
Target Recruit Count
12
Registration Number
NCT00636077
Locations
🇺🇸

University of Louisville, Kidney Disease Program, Louisville, Kentucky, United States

Molecule Removal and Ease of Use: A Comparison of Two Different Dialyzers

Not Applicable
Completed
Conditions
Chronic Kidney Disease
Interventions
Device: Polyflux 210H dialyzer
Device: Polyflux HD-C4
First Posted Date
2008-03-14
Last Posted Date
2025-03-24
Lead Sponsor
Vantive Health LLC
Target Recruit Count
12
Registration Number
NCT00636389
Locations
🇺🇸

DaVita Clinical Research Facility, Minneapolis, Minnesota, United States

Ex Vivo Microbiological Assessment of an Anti-biofilm Catheter in Acute Dialysis Application

Not Applicable
Completed
Conditions
Hemodialysis
Interventions
Device: GamCath® central venous catheter
Device: GamCath Dolphin® Protect central venous catheter
First Posted Date
2008-02-22
Last Posted Date
2025-03-13
Lead Sponsor
Vantive Health LLC
Target Recruit Count
69
Registration Number
NCT00621114
Locations
🇩🇪

Universitaetsklinikum Tuebingen, Tuebingen, Germany

Clinical Assessment of a New Catheter Surface Coating With Antimicrobial Properties

Not Applicable
Completed
Conditions
Renal Insufficiency
Interventions
Device: GamCath Dolphin® Protect central venous catheter
Device: GamCath® central venous catheter
First Posted Date
2008-02-22
Last Posted Date
2025-03-13
Lead Sponsor
Vantive Health LLC
Target Recruit Count
90
Registration Number
NCT00621712
Locations
🇩🇪

St. Joseph-Krankenhaus Berlin, Berlin, Germany

Recompensation of Exacerbated Liver Insufficiency With Hyperbilirubinemia and/or Encephalopathy and/or Renal Failure

Not Applicable
Completed
Conditions
Liver Failure
Interventions
Device: MARS device
Procedure: Standard medical therapy
First Posted Date
2008-02-13
Last Posted Date
2025-03-25
Lead Sponsor
Vantive Health LLC
Target Recruit Count
59
Registration Number
NCT00614146
Locations
🇧🇪

Universitaire Ziekenhuitzen, Leuven, Belgium

🇫🇷

Hôpital Huriez, Lille, France

🇫🇷

Hôpital Paul Brousse, Villejuif, France

and more 16 locations

Ease of Use Study for the Gambro Polyflux HD-C4 Small Dialyzer

Completed
Conditions
Hemodialysis
First Posted Date
2007-12-21
Last Posted Date
2025-03-11
Lead Sponsor
Vantive Health LLC
Target Recruit Count
24
Registration Number
NCT00579202
Locations
🇺🇸

Advanced Dialysis Center, Lanham, Maryland, United States

Fibrin Sealant Vascular Surgery Study

Phase 2
Completed
Conditions
Adjunct to Hemostasis in Vascular Surgery (Synthetic Vascular Grafts)
Interventions
Biological: FS VH S/D 500 s-apr, 60-seconds polymerization time
Biological: FS VH S/D 500 s-apr, 120-seconds polymerization time
Procedure: Manual compression with surgical gauze pads
First Posted Date
2007-12-19
Last Posted Date
2012-11-27
Lead Sponsor
Baxter Healthcare Corporation
Target Recruit Count
101
Registration Number
NCT00576420

IMPENDIA- PEN VS Dianeal Only Improved Metabolic Control In Diabetic CAPD and APD Patients

Phase 3
Completed
Conditions
ESRD
Diabetes
Interventions
Drug: Physioneal
Drug: Nutrineal
First Posted Date
2007-12-05
Last Posted Date
2025-03-13
Lead Sponsor
Vantive Health LLC
Target Recruit Count
43
Registration Number
NCT00567398
Locations
🇦🇺

Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia

🇦🇺

Westmead Hospital, Sydney, New South Wales, Australia

🇦🇺

Liverpool Hospital, Sydney, New South Wales, Australia

and more 13 locations

IMPENDIA- PEN VS Dianeal Only Improved Metabolic Control In Diabetic CAPD and APD Patients

Phase 4
Completed
Conditions
ESRD
Diabetes
APD
CAPD
Interventions
Drug: Physioneal
Drug: Nutrineal
First Posted Date
2007-12-05
Last Posted Date
2025-03-13
Lead Sponsor
Vantive Health LLC
Target Recruit Count
137
Registration Number
NCT00567489
Locations
🇭🇰

Prince of Wales Hospital Chinese University of Hong Kong, Sha Tin, N.t., Hong Kong

🇭🇰

Alice Ho Miu Ling Nethersole Hospital, Tai Po, N.t., Hong Kong

🇰🇷

Kyungpook National University Hospital, Daegu, Korea, Republic of

and more 16 locations
© Copyright 2025. All Rights Reserved by MedPath